Showing 20 of 86 recruiting trials for “Carcinoma of esophagus”
Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)
A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
👨⚕️ Ying Yuan, M.D, Second Affiliated Hospital, School of Medicine, Zhejiang University📍 2 sites📅 Started Aug 2023View details ↗
RecruitingNCT06431100 ↗
a Single-arm, Single-center, Open Clinical Study
Study to Evaluate EnteroTracker® as a Sampling Method to Screen for Barrett's Esophagus/Esophageal Cancer
Liquid Biopsies in Esophageal Cancer
👨⚕️ Jeroen Dekervel, MD, Universitaire Ziekenhuizen KU Leuven📍 4 sites📅 Started Mar 2023View details ↗
RecruitingNCT05698992 ↗
Rehabilitation and Recovery for Persons with Esophageal or Gastric Cancer
RecruitingNCT05952661 ↗
Minimally Residual of Esophageal Cancer 001
👨⚕️ Wenbin Shen, PhD, Hebei Medical University Fourth Hospital📍 1 site📅 Started Feb 2023View details ↗
RecruitingNCT06790797 ↗
Investigating the Biomarkers in Tumor and Peripheral Blood to Evaluate the Efficacy of Cancer Immunotherapy in Chest Cancer Patients
A Study Involving Neoadjuvant Chemoradiotherapy with Hypofractionated Radiotherapy in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma
Perioperative Analgesia Modes in Minimally Invasive Esophagectomy
🏥 Cancer Institute and Hospital, Chinese Academy of Medical Sciences📍 1 site📅 Started Oct 2022View details ↗
RecruitingNCT06009705 ↗
Toripalimab Combined With Radiotherapy and S-1 for Older Patients With Esophageal Cancer
👨⚕️ Wenbin Shen, PhD, Hebei Medical University Fourth Hospital📍 1 site📅 Started Oct 2022View details ↗
RecruitingNCT06515964 ↗
China Early Esophageal Cancer Cohort
The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer
Anti-Migration System for Anti-reflux Oeso-gastric Stent (ANTIMIG)
Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC
A Phase II Study of CRT Combined With QL1706 in ESCC Patients
RecruitingNCT05443841 ↗
Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005)
RecruitingNCT06393140 ↗
The Study on the Mechanism of Radiotherapy-elicited Immune Response
Surgery or Chemoradiotherapy for Cervical Esophageal Cancer
👨⚕️ Jie He, MD, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College📍 1 site📅 Started Apr 2022View details ↗
TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer
🏥 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)📍 1 site📅 Started Mar 2022View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →